Gleni Quispe-Callo

Gleni Quispe-Callo

Auto-generated profile, based on publicly available information

Gleni Quispe-Callo

School of Psychology, Universidad Nacional de San Agustín, Arequipa, Perú

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 August 2024 in JMIR Mental Health
Verified
Journal Article
Open access
David Villarreal-ZegarraDavid Villarreal-Zegarra
David Villarreal-Zegarra
CRChristian Mahony Reategui-Rivera
Christian Mahony Reategui-Rivera
JGJackeline García-Serna
Jackeline García-Serna
GQGleni Quispe-Callo
Gleni Quispe-Callo
GLGabriel Lázaro-Cruz
Gabriel Lázaro-Cruz
JFJoseph Finkelstein
Joseph Finkelstein
Background: The introduction of natural language processing (NLP) technologies has significantly enhanced the potential of self-administered interventions for treating anxiety and depression by improving human-computer interactions. Although these advances, particularly in complex models such as generative artificial intelligence (AI), are highly promising, robust evidence validating the effectiveness of the interventions remains sparse. Objective: The aim of this study was to determine whether self-administered interventions based on NLP models can reduce depressive and anxiety symptoms. Methods: We conducted a systematic review and meta-analysis. We searched Web of Science, Scopus, MEDLINE, PsycINFO, IEEE Xplore, Embase, and Cochrane Library from inception to November 3, 2023. We included studies with participants of any age diagnosed with depression or anxiety through professional consultation or validated psychometric instruments. Interventions had to be self-administered and based on NLP models, with passive or active comparators. Outcomes measured included depressive and anxiety symptom scores. We included randomized controlled trials and quasi-experimental studies but excluded narrative, systematic, and scoping reviews. Data extraction was performed independently by pairs of authors using a predefined form. Meta-analysis was conducted using standardized mean differences (SMDs) and random effects models to account for heterogeneity. Results: In all, 21 articles were selected for review, of which 76% (16/21) were included in the meta-analysis for each outcome. Most of the studies (16/21, 76%) were recent (2020-2023), with interventions being mostly AI-based NLP models (11/21, 52%); most (19/21, 90%) delivered some form of therapy (primarily cognitive behavioral therapy: 16/19, 84%). The overall meta-analysis showed that self-administered interventions based on NLP models were significantly more effective in reducing both depressive (SMD 0.819, 95% CI 0.389-1.250; P<.001) and anxiety (SMD 0.272, 95% CI 0.116-0.428; P=.001) symptoms compared to various control conditions. Subgroup analysis indicated that AI-based NLP models were effective in reducing depressive symptoms (SMD 0.821, 95% CI 0.207-1.436; P<.001) compared to pooled control conditions. Rule-based NLP models showed effectiveness in reducing both depressive (SMD 0.854, 95% CI 0.172-1.537; P=.01) and anxiety (SMD 0.347, 95% CI 0.116-0.578; P=.003) symptoms. The meta-regression showed no significant association between participants’ mean age and treatment outcomes (all P>.05). Although the findings were positive, the overall certainty of evidence was very low, mainly due to a high risk of bias, heterogeneity, and potential publication bias. Conclusions: Our findings support the effectiveness of self-administered NLP-based interventions in alleviating depressive and anxiety symptoms, highlighting their potential to increase accessibility to, and reduce costs in, mental health care. Although the results were encouraging, the certainty of evidence was low, underscoring the need for further high-quality randomized controlled trials and studies examining implementation and usability. These interventions could become valuable components of public health strategies to address mental health issues. Trial Registration: PROSPERO International Prospective Register of Systematic Reviews CRD42023472120; https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42023472120

25 May 2023 in PLOS ONE
Verified
Journal Article
Open access
PDF file
CRCristian Ramos-Vera
Cristian Ramos-Vera
GCGleni Quispe Callo
Gleni Quispe Callo
MDMiguel Basauri Delgado
Miguel Basauri Delgado
JSJosé Vallejos Saldarriaga
José Vallejos Saldarriaga
Jacksaint SaintilaJacksaint Saintila
Jacksaint Saintila
Depression in young people is considered a public health problem, given that it affects their personal, social, and academic lives; therefore, early detection of depressive symptoms is of importance for a favorable prognosis. This study aimed to estimate the psychometric properties of the second edition of the Reynolds Adolescent Depression Scale (RADS-2) in Peruvian adolescents. The sample was composed of 917 Peruvian adolescents, aged 13 to 18 years (M = 15,241, SD = 1,020), who were selected from two public educational institutions in Metropolitan Lima. Confirmatory factor analysis supported the 25-item model with the four-dimensional structure and its overall and interdimensional reliability. This structure was found to be gender invariant. Finally, network analysis was performed to assess the relationships and centralities of the depressive symptoms of the validated version of the RADS-2. The results show that the RADS-2 measure is a consistent and reliable test that yields valid results in the Peruvian adolescent context.

21 June 2024 in International Journal of Testing
Verified
Journal Article
Closed access
CRCristian Ramos-Vera
Cristian Ramos-Vera
GQGleni Quispe-Callo
Gleni Quispe-Callo
JSJosé Vallejos Salvarriaga
José Vallejos Salvarriaga
Kıvanç UzunKıvanç Uzun
Kıvanç Uzun
Jacksaint SaintilaJacksaint Saintila
Jacksaint Saintila

15 April 2024 in JMIR Preprints
Verified
Preprint
Open access
David Villarreal-ZegarraDavid Villarreal-Zegarra
David Villarreal-Zegarra
JGJackeline García-Serna
Jackeline García-Serna
GQGleni Quispe-Callo
Gleni Quispe-Callo
GLGabriel Lázaro-Cruz
Gabriel Lázaro-Cruz
GCGianfranco Centeno-Terrazas
Gianfranco Centeno-Terrazas
JFJoseph Finkelstein
Joseph Finkelstein
BACKGROUND The introduction of Natural Language Processing (NLP) technologies has significantly enhanced the potential of self-directed interventions for treating anxiety and depression by improving human-computer interactions. Despite these advancements, particularly in AI and Large Language Models (LLMs), robust evidence validating their effectiveness remains sparse. OBJECTIVE To determine whether interventions based on NLP models can reduce depressive and anxiety symptoms. METHODS Our study was a systematic review, and the protocol was registered in PROSPERO (CRD42023472120). The databases we used for the systematic review are Web of Science, SCOPUS, MEDLINE (via PubMed), PsycINFO (via EBSCO), IEEE Xplore, EMBASE (via EBSCO), and Cochrane Library. The quality of the included studies was assessed using the JBI Critical Appraisal Tools. RESULTS 21 articles were selected for review, and 16 were included in the meta-analysis for each outcome. The overall meta-analysis showed that self-administered interventions based on NLP models were significantly more effective in reducing depressive symptoms (SMD=0.819; 95%CI: 0.389-1.250; p<0.001) and anxiety symptoms (SMD=0.272; 95% CI: 0.116-0.428; p=0.001) compared with various control conditions. In subgroup analysis, AI-based NLP was shown to be effective in reducing depressive (SMD=1.059 [0.520 to 1.597]; p<0.001) and anxiety symptoms (SMD=0.302 [0.073 to 0.532]; p=0.010) compared with pooled control conditions. Also, NLP-based interventions overall outperform psychoeducation and bibliotherapy in reducing both depressive (SMD=1.481 [0.368 to 2.594]; p=0.009) and anxiety symptoms (SMD=0.561 [0.195 to 0.927]; p=0.003). In addition, these interventions are more effective than waitlist or no intervention in reducing anxious symptoms (SMD=0.196 [0.042 to 0.351]; p=0.013). CONCLUSIONS Our findings support the usefulness of self-applied NLP-based interventions in alleviating widely prevalent mental health problems such as depressive and anxious symptoms. CLINICALTRIAL Protocol was registered in PROSPERO (CRD42023472120)

29 January 2026 in Discover Public Health
Verified
Journal Article
Open access
CRCristian Ramos-Vera
Cristian Ramos-Vera
GQGleni Quispe-Callo
Gleni Quispe-Callo
SSSussan G. Segura-Míñope
Sussan G. Segura-Míñope
YMYAQUELIN EVELING CALIZAYA MILLA
YAQUELIN EVELING CALIZAYA MILLA
Jacksaint SaintilaJacksaint Saintila
Jacksaint Saintila